文献速递心力衰竭与心肌病

营养不良对心力衰竭合并继发性二尖瓣反流患者的影响:COAPT 试验

Impact of Malnutrition in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial.
PubMed 文献 · J Am Coll Cardiol · 2023-06-09

COAPT 试验事后分析纳入 552 例心力衰竭合并重度继发性二尖瓣反流患者,用老年营养风险指数(GNRI)评估基线营养不良风险,GNRI≤98 定义为营养不良。中位 GNRI 为 109,17.0% 存在营养不良;营养不良者 4 年全因死亡率更高(68.3% vs 52.8%,P=0.001),且为 4 年死亡的独立预测因素(adj-HR 1.37;95%CI 1.03-1.82;P=0.03)。TEER 联合 GDMT 较单用 GDMT 降低死亡(adj-HR 0.65;95%CI 0.51-0.82;P=0.0003)和心衰住院(adj-HR 0.46;95%CI 0.36-0.56),且在有/无营养不良者中一致。

要点

  • COAPT 试验中约 1/6 心衰合并重度 SMR 患者存在营养不良(GNRI≤98)。
  • 营养不良与 4 年全因死亡增加独立相关,但与心衰住院无关。
  • TEER 降低死亡和心衰住院的获益在有/无营养不良者中一致。

核心结论

  • 营养不良在 COAPT 试验心衰合并重度 SMR 患者中占 17.0%,与 4 年全因死亡增加独立相关,但与心衰住院无关。
  • TEER 联合 GDMT 较单用 GDMT 降低死亡和心衰住院,且在有/无营养不良患者中获益一致。

研究设计与样本

  • COAPT 试验事后分析,纳入 552 例心衰合并重度继发性二尖瓣反流患者,随机接受 TEER(MitraClip)联合 GDMT 或单用 GDMT。
  • 采用经验证的老年营养风险指数(GNRI)评估基线营养不良风险,GNRI≤98 定义为营养不良,GNRI>98 为无营养不良,随访至 4 年。

主要发现

  • 552 例患者中位基线 GNRI 为 109(IQR:101-116),94 例(17.0%)存在营养不良。
  • 营养不良者 4 年全因死亡率为 68.3%,无营养不良者为 52.8%(P=0.001)。
  • 多变量分析显示基线营养不良(adj-HR:1.37;95%CI:1.03-1.82;P=0.03)和随机接受 TEER 联合 GDMT(adj-HR:0.65;95%CI:0.51-0.82;P=0.0003)均为 4 年死亡的独立预测因素。
  • GNRI 与 4 年心衰住院率无关,但 TEER 治疗降低心衰住院(adj-HR:0.46;95%CI:0.36-0.56)。
  • TEER 降低死亡(adj-Pinteraction=0.46)和心衰住院(adj-Pinteraction=0.67)的效应在有/无营养不良患者中一致。

关键数值与推荐

  • 营养不良定义:GNRI≤98;无营养不良:GNRI>98。
  • 主要终点为全因死亡,随访 4 年。

临床怎么用

  • 对心衰合并重度继发性二尖瓣反流患者,可用 GNRI 评估营养不良风险以辅助风险分层。
  • 营养不良不应作为排除 TEER 的理由,因 TEER 在有/无营养不良患者中均降低死亡和心衰住院。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although malnutrition is associated with poor prognosis in several diseases, its prognostic impact in patients with heart failure (HF) and secondary mitral regurgitation (SMR) is not understood. OBJECTIVES: The purpose of this study was to assess the prevalence and impact of malnutrition in HF patients with severe SMR randomized to transcatheter edge-to-edge repair (TEER) with the MitraClip plus guideline-directed medical therapy (GDMT) vs GDMT alone in the COAPT trial. METHODS: Baseline malnutrition risk was calculated using the validated geriatric nutritional risk index (GNRI) score. Patients were categorized as having "malnutrition" (GNRI ≤98) vs "no malnutrition" (GNRI >98). Outcomes were assessed through 4 years. The primary endpoint of interest was all-cause mortality. RESULTS: Among 552 patients, median baseline GNRI was 109 (IQR: 101-116); 94 (17.0%) had malnutrition. All-cause mortality at 4 years was greater in patients with vs those without malnutrition (68.3% vs 52.8%; P = 0.001). Using multivariable analysis, both baseline malnutrition (adjusted-HR [adj-HR]: 1.37; 95% CI: 1.03-1.82; P = 0.03) and randomization to TEER plus GDMT compared with GDMT alone (adj-HR: 0.65; 95% CI: 0.51-0.82; P = 0.0003) were independent predictors of 4-year mortality. In contrast, GNRI was unrelated to the 4-year rate of heart failure hospitalization (HFH), although TEER treatment reduced HFH (adj-HR: 0.46; 95% CI: 0.36-0.56). The reductions in death (adj-Pinteraction = 0.46) and HFH (adj-Pinteraction = 0.67) with TEER were consistent in patients with and without malnutrition. CONCLUSIONS: Malnutrition was present in 1 of 6 patients with HF and severe SMR enrolled in COAPT and was independently associated with increased 4-year mortality (but not HFH). TEER reduced mortality and HFH in patients with and without malnutrition. (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation [The COAPT Trial] and COAPT CAS [COAPT]; NCT01626079).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Scotti, Coisne, Granada, et al. Impact of Malnutrition in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial. J Am Coll Cardiol. 2023. PMID: 37306651. doi:10.1016/j.jacc.2023.04.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。